axillary nodal examination in breast cancer: how much is enough? evidence for a new minimum

نویسندگان

sgd gangadaran department of medical oncology, government royapettah hospital, chennai, india

چکیده

background: axillary nodal spread is an established prognostic factor in breast cancer. axillary nodal dissection and subsequent pathological examination is considered the gold standard technique of assessing the axilla for metastatic disease. a minimum of ten level i axillary nodes are required to be examined before an axillary specimen can be reliably labeled as disease free. this recommendation is based on a mathematical prediction model and such methodology has certain inherent limitations. in this study, we sought to revisit this concept of minimum nodes required to deem an axilla as true negative by using a linear correlation model. methods: medical records of 165 consecutive breast cancer patients attending a medical oncology department for adjuvant therapy were assessed for inclusion. one hundred and forty-five breast cancer patients in clinical stages i-iii met the inclusion criteria. patients referred after neoadjuvant chemotherapy, breast conservation surgery, palliative mastectomy, and mastectomy for metastatic disease were excluded from the study. the study samples were segregated into groups of 1-5, 6-10, 11-15, 16-20, 21-25, and more than 25 nodes. a linear regression model was used to assess the association between the nodal positivity and nodal groups. the spearman rho with p value was calculated for the model. factors influencing the nodal yield of an axillary specimen were selected from the published literature and the same variables were evaluated in the study cohort. results: a total of 1882 nodes were harvested from 145 axillary specimens and 320 nodes were positive for metastatic disease. the mean nodal harvest per axillary specimen was 11 nodes. the linear correlation model evaluating the association between nodal positivity and total nodal yield showed a spearman correlation coefficient of rho = - 0.82 with p=0.04. to avoid bias due to the uneven sample size, the nodal ratio was calculated for each group and the linear association model reapplied to test the association with the total nodal harvest. a spearman rho of r = -0.94 with p=0.004 was obtained. the nodal groups tested for significance showed p= 0.0001 for the group 1-15 nodes. evaluation of the factors likely to influence nodal yield showed that age (p=0.15) and obesity (p=0.67) had no effect on the nodal harvest. tumor stage (p<0.001) and operating surgeon (p=0.0001) had a significant effect on the total nodal harvest. conclusions: the recommendation of a minimum of ten axillary nodes to be examined to determine true negativity of an axillary specimen needs reassessment. a new minimum of fifteen nodes is suggested before an axillary specimen is reliably deemed free of metastatic disease.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

How much is enough? The continuing debate on the axillary lymph node dissection in breast cancer.

The Permanente Journal/ Spring 2007/ Volume 11 No. 2 Since the Halsted radical mastectomy was introduced in 1894, breast cancer treatment has undergone major changes. More than a century later, breast conserving surgery is now accepted in the treatment armamentarium of early breast cancer. However, the role of axillary lymph node dissection (ALND) in breast cancer treatment continues to be cont...

متن کامل

How much vancomycin dose is enough for the MRSA infection in pediatric patients with various degrees of renal function?

Today, an increase in vancomycin dose has been proposed to ensure efficacy. However, the risk of nephrotoxicity will increase with the dose. This study was aimed at evaluating the dosage regimens of vancomycin in pediatric patients based on pharmacokinetics/pharmacodynamics (PK/PD) and to optimize dosage individualization. Population pharmacokinetics analysis was performed on 155 Chinese childr...

متن کامل

Escalation: How Much is Enough?

often the subject of fierce debate. Cost increases are determined by dynamic relationships between many factors, including acts of nature, interest rates, oil prices, global commodity markets, wars, wage rates, and the overall health of the economy, as well as supply and demand for the required goods or services. How much escalation is enough? Are the recent price increases temporary aberration...

متن کامل

How much REST is enough?

Recent papers published in Nature by Guardavaccaro et al. and Westbrook et al. describe a nexus of two masters of negative regulation of protein levels. Both of these studies establish that the transcriptional repressor REST/NRSF is regulated by the highly versatile ubiquitin protein ligase (E3) SCF(beta-TrCP), adding a new dimension to the relationship between the ubiquitin-proteasome system a...

متن کامل

How much vancomycin dose is enough for the MRSA infection in pediatric patients with various degrees of renal function?

Today, an increase in vancomycin dose has been proposed to ensure efficacy. However, the risk of nephrotoxicity will increase with the dose. This study was aimed at evaluating the dosage regimens of vancomycin in pediatric patients based on pharmacokinetics/pharmacodynamics (PK/PD) and to optimize dosage individualization. Population pharmacokinetics analysis was performed on 155 Chinese childr...

متن کامل

Genomic testing in colorectal cancer: how much is enough?

Colorectal cancer has been extensively molecularly characterized in recent years. In addition to furthering the understanding of biologic hallmarks of the disease, the ultimate goal of these studies has been to provide tools that would allow us to identify subgroups of colorectal cancer with prognostic and predictive implications, either for the anticipation of toxicity or for selection of the ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
archives of breast cancer

جلد ۳، شماره ۴، صفحات ۱۲۶-۱۲۹

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023